Bioscience Animal Health PCL (BKK:BIS) ROCE % : 11.69% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bioscience Animal Health PCL ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioscience Animal Health PCL's annualized ROCE % for the quarter that ended in Dec. 2023 was 11.69%.

Bioscience Animal Health PCL ROCE % Historical Data

The historical data trend for Bioscience Animal Health PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioscience Animal Health PCL ROCE % Chart

Bioscience Animal Health PCL Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

34.42

33.95

33.62

14.99

8.62

Bioscience Animal Health PCL Quarterly Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial										9.65	4.62	7.47	10.88	11.69

Bioscience Animal Health PCL ROCE % Calculation

Bioscience Animal Health PCL's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	68.286	/	( ( (1085.14 - 303.791)	+	(1228.092 - 424.171) )	/ 2 )
	=	68.286	/	( (781.349	+	803.921)	/ 2 )
	=	68.286	/	792.635
	=	8.62 %

Bioscience Animal Health PCL's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	93.024	/	( ( (1168.878 - 381.861)	+	(1228.092 - 424.171) )	/ 2 )
	=	93.024	/	( ( 787.017	+	803.921 )	/ 2 )
	=	93.024	/	795.469
	=	11.69 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Bioscience Animal Health PCL (BKK:BIS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioscience Animal Health PCL ROCE % Related Terms

Thank you for viewing the detailed overview of Bioscience Animal Health PCL's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioscience Animal Health PCL (BKK:BIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioscience Animal Health PCL (BKK:BIS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bond Street Road, No. 479, 4th Floor, Muangthongthani, Bangphut, Pakkret, Nonthaburi, THA, 11120

Website

https://www.bis-group.com

Bioscience Animal Health PCL engaged in manufacture, import and distribution of pharmaceutical supplies, medical devices, equipment, and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand.